Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.

Date publication

janvier 2022

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FAVIER Laure , Dr FUMET Jean-David

Tous les auteurs :
Romeo C, Le Saux O, Jacobs M, Joly F, Ferron G, Favier L, Fumet JD, Isambert N, Colombo PE, Sabatier R, Bastide L, Charreton A, Devouassoux-Shisheboran M, Gertych W, Dubot C, Bello Roufai D, Bataillon G, Berton D, Kalbacher E, Pautier P, Pomel C, Cornou C, Treilleux I, Lardy-Cleaud A, Ray-Coquard I

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35053517

Résumé

Gynecological carcinosarcomas are rare and aggressive diseases, with a poor prognosis. The rarity of these tumors explains the lack of robust and specific data available in the literature. The objective of this study was to investigate the impact of initial adjuvant treatment and recurrent therapeutic strategies.

Mots clés

TMRG network, adjuvant treatment, chemotherapy, cytotoxic agent, ovarian carcinosarcoma, rare cancer, uterine carcinosarcoma

Référence

Cancers (Basel). 2022 Jan 12;14(2):